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Abstract
Background: Action to avert maternal and child mortality was propelled by the Millennium Development Goals
(MDGs) in 2000. The Latin American and Caribbean (LAC) region has shown promise in achieving the MDGs in
many countries, but preventable maternal, neonatal and child mortality persist. Furthermore, preventable stillbirths
are occurring in large numbers in the region. While an effective set of maternal, newborn and child health (MNCH)
interventions have been identified, they have not been brought to scale across LAC.
Methods: Baseline data for select MNCH interventions for 27 LAC countries that are included in the Lives Saved
Tool (LiST) were verified and updated with survey data. Three LiST projections were built for each country: baseline,
MDG-focused, and All Included, each scaling up a progressively larger set of interventions for 2015 - 2030. Impact
was assessed for 2015 - 2035, comparing annual and total lives saved, as projected by LiST.
Results: Across the 27 countries 235,532 stillbirths, and 752,588 neonatal, 959,393 under-five, and 60,858 maternal
deaths would be averted between 2015 and 2035 by implementing the All-Included intervention package,
representing 67 %, 616 %, 807 % and 101 % more lives saved, respectively, than with the MDG-focused
interventions. 25 % neonatal deaths averted with the All-Included intervention package would be due to asphyxia,
42 % from prematurity and 24 % from sepsis.
Conclusions: Our modelling suggests a 337 % increase in the number of lives saved, which would have enormous
impacts on population health. Further research could help clarify the impacts of a comprehensive scale-up of the
full range of essential MNCH interventions we have modelled.
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Background
International action to avert maternal and child mortal-
ity was propelled with the adoption of the Millennium
Development Goals (MDGs) in 2000. In particular, MDG
4 and 5 call for the reduction of child mortality and im-
proving maternal health [1]. While progress has been
made towards the achievement of both goals 4 and 5, pre-
ventable maternal and child mortality persists [1–3].
Moreover, nearly half of all under-five mortality occurs
during the neonatal period [2, 4].
As the MDGs transition to the Sustainable Develop-
ment Goals (SDGs) this year, the Latin American and
Caribbean (LAC) region has shown progress in achiev-
ing the MDGs at the regional and national level [5].
However, preventable maternal, neonatal and child mor-
tality persists across LAC [2, 4]. Furthermore, prevent-
able stillbirths, which were not included in the MDGs,
are occurring in large numbers, particularly in LAC [3].
Research has shown that there are efficacious, cost-
effective interventions that can prevent these deaths, in-
cluding stillbirths [4, 6–9]. However, these maternal,
newborn and child health (MNCH) interventions are
not universally included in the provision of care to women
and children across the LAC region. Furthermore, inequi-
ties in access to effective MNCH interventions persist
across the region, which are potentially leading to even
more deaths among mothers and children [4, 10, 11].
Evidence on the potential reduction in maternal, neo-
natal and child mortality, and stillbirths, from various
packages of interventions exists, but their implementa-
tion remains limited. We conducted an analysis with the
Lives Saved Tool (LiST) to compare the number of
deaths potentially averted when scaling up two different
set of MNCH interventions: one narrowly restricted to
interventions needed to deliver the explicit MDG tar-
gets; the second set of interventions adding additional
MNCH interventions that address other known causes
of maternal, neonatal and child mortality. This study
aims to help inform decisions on the scope of the re-
sponse needed to effectively address preventable mater-
nal, neonatal and child deaths, and stillbirths, in LAC
during the post-2015 development agenda.
Methods
All analyses were carried out in LiST, modelling software
that projects the number of deaths and lives saved with
selected intervention packages being scaled up over a
specified time period, using Spectrum version 5.34 [12].
We identified 28 interventions in LiST that impact
maternal, neonatal and child mortality, and stillbirth,
which were included in this study (Table 1). Intervention
variables were defined according to the LiST manual
[13]. The 27 LAC countries with panels in LiST were in-
cluded in this analysis: Argentina, Bahamas, Barbados,
Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba,
Dominican Republic, Ecuador, El Salvador, Guatemala,
Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua,
Panama, Paraguay, Peru, Suriname, Trinidad & Tobago,
Uruguay, and Venezuela.
For each country with national-level data in LiST
(Belize, Bolivia, Brazil, Colombia, Costa Rica, Cuba,
Dominican Republic, Ecuador, El Salvador, Guatemala,
Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua,
Panama, Paraguay, Peru, Suriname, Venezuela), we veri-
fied the coverage at baseline, 2014, with the most recent
national-level survey data (e.g., Multiple Indicator Clus-
ter Surveys [MICS], Demographic and Health Surveys
[DHS]), a specific dataset (e.g., immunization coverage,
antibiotics for pneumonia), or based on expert opinion
for each of the 28 interventions (Table 1). When no
country data was available for certain interventions
(Kangaroo Mother Care and the break-down of the pro-
portion of facility deliveries at each level of care), we
consulted a regional expert to determine the most
accurate source for baseline coverage for each vari-
able. For countries without national-level data in
LiST (Argentina, Bahamas, Barbados, Chile, Trinidad
& Tobago, Uruguay), we replaced the regionally de-
rived estimated values in LiST with coverage esti-
mates obtained from the most recent standardized
surveys or similar global datasets [14–41], (Add-
itional file 1). All baseline data used in this analysis
is available in Additional file 2.
Three projections were used for creating three LiST
scenarios for each country: baseline, MDG (basic), and
All-Included (All-In). The baseline projection assumes
no additional intervention scale up over the study
period, bolding coverage rates constant throughout for
all interventions. The MDG scenario added to the base-
line scenario those interventions narrowly focused on
achieving specific MDG targets, taking these to 95-
100 % coverage, depending on the variable, by 2030. The
All-In scenario added additional high impact interven-
tions to the MDG scenario to address other causes of
MNCH mortality (Table 1, Additional file 3). All other
interventions that could be modelled within LiST were
left constant. Family Planning (FP) was excluded, as
Total Fertility Rates and Contraceptive Prevalence Rates
in many LAC countries are close to national targets, as
evidenced by an average TFR of 2.2 in LAC [42]. Our
paper seeks to examine the potential impact on Neo-
natal, U5 and Maternal deaths in LAC that will come
from expansion of non-FP but high impact interven-
tions, going beyond the narrow set required to meet the
MDGs. Nonetheless, the impact of FP in LAC, especially
on adolescents, requires additional and urgent study.
While investment in the MDG or All-In intervention
packages may result in investment in spillover effects
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that could influence the coverage rates of other interven-
tions, there have not been sufficient scientific studies in
published literature as to how to credibly estimate situ-
ations of co-coverage, or provide guidance on how to
estimate their impact. Thus, our results are conserva-
tive estimates of the number of lives saved from the
scale-up of each intervention package. One aim of this
study is to help add to the evidence of what should be
included in essential packages of health interventions,
based on available data and historical scale-up trends in
the region.
All three projections were from 2015 to 2035, to en-
sure the impact of vaccination coverage during the
intervention period is included in the results of the ana-
lysis (Additional file 4). MDG (basic) and All-In pack-
ages of interventions were scaled-up between 2015 and
2030, and then kept constant between 2030 and 2035.
Scale-up of each intervention was modelled either as lin-
ear, the same increase in coverage year-over-year, or
front-loaded, with a rapid scale-up in the first years and
a more gradual increase in coverage for the remainder of
the intervention period (Table 1). This is in line with
how programs in the region have traditionally scaled-up
either the actual intervention being modelled, or a simi-
lar intervention. For the few countries with baseline
coverage for a specific indicator greater than the MDG
Table 1 Interventions included in scale-up of service coverage intervention packages, by LiST grouping
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endline target coverage, the existing baseline coverage
was held constant through 2035, for each scenario.
The MDG (basic) intervention package was the linear
scale-up of: i) pregnant women receiving antenatal care
to 100 %, ii) measles vaccination for children to 100 %;
and iii) the front-loaded scale-up of facility-based births
with access to Comprehensive Emergency Obstetric Care
(CEmOC) to 65 %, facility-based births with access to
Basic Emergency Obstetric Care (BEmOC) to 30 %, and
assisted home deliveries to 5 % (Table 1). If delivery at
home – both unassisted and assisted – was less than 5 %
at baseline the proportion of home births were scaled to
assisted delivery at home (range of x = 0.0 % - 4.9 %); the
remaining proportion (5.0 %-x) was included in births
with access to BEmOC. The basic package was purpose-
fully designed to assess the impact of narrowly investing
only in achieving and attaining MDG specific targets.
The All-In intervention scenario was built from the
MDG scenario for each country, but purposively in-
cluded additional interventions, available in LiST, likely
to reflect the broader scope of the Sustainable Develop-
ment Goals (SDGs). The scale-up, baseline and target
coverage of all interventions from the MDG scenario
were maintained, to ensure full comparability with the
All-in Scenario. Additional interventions included in the
All-In intervention package were managed as follows.
There was a linear scale up, by 2020, of: tetanus toxoid
vaccination for women during pregnancy to 98 %; ex-
clusive breastfeeding for children up to six months old
to 90 %; oral rehydration solution for children with
diarrhea to 95 %; and antibiotics for children with
pneumonia to 95 %. It also included a front-loaded
scale up of the following vaccinations: Bacille Calmette-
Guerin (BCG); polio; diphtheria, pertussis and tetanus
(DTP); Haemophilus Influenzae Type B (Hib); Hepatitis
B; pneumococcal; and rotavirus to 100 % by 2030. In
addition, it incorporated the front-loaded scale-up by
2025 of: home-births with a skilled birth attendant to
1 %; essential care to 1 %; BEmOC to 1 %; and CEmOC
to 97 %. The nine final interventions included for the
All-In intervention were scaled-up to match the cover-
age figures for the delivery care type they are typically
associated with. Thus, coverage with thermal care and
oral antibiotics matched the sum of essential care and
home-based delivery. In the same light, clean postnatal
practices and Chlorhexidine (cord care) matched the
sum of all three facility-based delivery options – essential
care, BEmOC and CEmOC. Injectable antibiotics were
added to match BEmOC coverage, while interventions in-
cluded under full supportive care for sepsis/pneumonia
matched CEmOC coverage. For coverage of magnesium
sulfate (MgSO4), maternal sepsis case management, and
full supportive care for prematurity, these were set to match
the sum of BEmOC plus CEmOC coverage (Table 1).
Estimates of the total number of baseline deaths in
each group annually in the LAC region were derived
from published literature and interagency estimate
reports [3, 43, 44].
The LiST outputs were generated using country-
specific projections to determine the total number of
deaths, lives saved, and mortality rates over the study
period under each scenario (baseline, MDG, All-In).
These outputs were categorized by intervention and by
cause of death, and disaggregated by sub-population: ne-
onates, children under five, and women. Two examples
of intervention scale-up and resulting deaths averted can
be found in Additional file 1. These were then aggre-
gated for the entire 27 LAC countries studied to assess
the differential impact between the scenarios on still-
births, and on neonatal, under-five, and maternal deaths.
Note that outcomes of neonates were included in the
under-five group figures for lives saved, in-line with LiST
convention [1, 2, 4, 5]. Lives saved, deaths and mortality
rates under each scenario were projected for neonates
from asphyxia, sepsis and prematurity.
Results
All four groups – stillbirths, neonates, under-fives and
maternal – had a significantly higher number of lives
saved between 2016, the first year lives were saved from
interventions scaled up in 2015, and 2035 with the All-
In Intervention package, compared to the MDG inter-
vention package. This is consistent with the reasoning
for expanding the scope of the health SDGs as compared
to the MDGs [45]. The MDG intervention package pre-
vented: 141,157 stillbirths, 105,160 neonatal deaths,
105,756 under-five deaths, and 30,339 maternal deaths,
between 2016 and 2035. The All-In intervention package
prevented: 235,532 stillbirths, 752,588 neonatal deaths,
959,393 under-five deaths, and 60,858 maternal deaths
during the same time period. The All-In scenario shows
a 67 % increase in lives saved for stillbirths, 616 % for
neonates, 807 % for under-fives and 101 % for mothers,
compared to the MDG intervention package, reflecting
the addition of high-impact interventions addressing
major drivers of neonatal and maternal deaths. Approxi-
mately three-quarters (78 %) of additional under-five
lives saved with the implementation of the All-In inter-
vention package would be during the neonatal period,
consistent with the distribution of deaths across the
under-fives. The remaining U5 lives saved result from
the increased birth cohort due to reduced neonatal mor-
tality. This increased number of children, combined with
increased coverage of other U5 interventions, leads to
many more children reaching their fifth birthday com-
pared to the narrower set of interventions under the
MDG scenario (Fig. 1). We note that U5 mortality figures
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include ages 0 to 5 years, thus including the impact of re-
ductions in the neonatal period (0 to 12 months of age).
Based on the average number of deaths that occurred
in each of the four groups annually, between 2009-2013,
the MDG intervention saved between 3.4 % and 11.0 %
of deaths from stillbirth annually, and the All-In inter-
vention package saved between 7.6 % and 16.5 % of
deaths from stillbirth annually, primarily from scaling-up
facility based interventions for birth and the immediate
post-natal period. Between 3.5 % and 7.2 % of annual
neonatal deaths would be averted with the implementa-
tion of the MDG intervention package, and between
one-third (32.6 %) and nearly half (43.8 %) of annual
neonatal deaths would be averted with the implementa-
tion of the All-In intervention package. The MDG pack-
age would also avert between 1.9 % and 3.6 % of under-
five child deaths, as well as between 10.7 % and 22.7 %
of annual maternal deaths. The All-In package would
avert far greater under-five deaths – between 22.8 % and
28.0 % of all under-five deaths annually – and between
one-third (27.1 %) and two-fifths (39.1 %) of annual ma-
ternal deaths (Table 2).
The All-In intervention package resulted in a sub-
stantive increase in the number of lives saved year-
over-year in each age group compared the MDG inter-
vention package. The number of stillbirths averted and
neonatal, under-five and maternal lives saved annually,
compared to the MDG package, rose progressively.
Lives saved annually increased from 22,636 in 2016 to
116,470 in 2035 with the implementation of the All-In
intervention package. This represents a 415 % increase
in the number of lives saved in 2035 by the All-In inter-
vention package, compared to the MDG intervention
package (Fig. 2).
Neonatal asphyxia, sepsis and prematurity
Tens-of-thousands of neonates would be saved from
sepsis, asphyxia and prematurity with the scale-up of the
MDG intervention package. The number of neonatal
lives saved from asphyxia annually, compared to
Fig. 1 Total number of lives saved, by age group and intervention package, 2015-2035
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baseline, rose progressively from 613 in 2016 to 5,049 in
2035, saving 73,843 neonates from asphyxia between
2016 and 2035. For sepsis, implementation of the MDG
intervention package resulted in the number of neonatal
lives saved rising from 92 in 2016, to 697 in 2035, saving
11,798 neonates over 20 years. For prematurity, the
MDG intervention package saved 170 neonatal lives in
2016, 697 in 2035, and a total of 11,798 neonatal lives
over the twenty year period.
185,365, 313,423 and 177,302 neonatal deaths from as-
phyxia, prematurity and sepsis, respectively, would be
prevented with the implementation of the All-In scale-
up of interventions across the LAC region from 2016 to
2035 (Fig. 3). This represents a drastic increase in the
number of neonatal lives saved from each of these three
causes, compared to the MDG intervention package.
Nearly half (42 %) of all neonatal deaths prevented
with the All-In intervention package would have been
deaths attributed to prematurity. Another quarter (25 %)
of lives saved would have been lost to asphyxia, and an-
other quarter (24 %) of neonatal lives potentially saved
would have been saved from sepsis. Together, over half
a million neonatal lives in LAC would be saved from
prematurity, sepsis and asphyxia over the next 20 years
with the implementation of the All-In intervention
package. Of all the neonatal lives saved with the All-In
intervention package between 2016 and 2035, 90 % of
neonatal lives saved would be saved from asphyxia, sep-
sis and prematurity.
Discussion
In this paper, we present the potential impact on mater-
nal, newborn and child mortality of two sets of high-
impact interventions for which sufficient evidence exists
to model them using the LiST. One set represents
achieving universal health coverage (UHC) with a basic
set of interventions representing those specifically in-
cluded in the MDGs. A second set was designed to rep-
resent nearly universal coverage of a comprehensive
package of MNCH interventions proven to save lives.
The All-In intervention package analyzed would save
the lives of over an additional 1.6 million mothers and
children across the LAC region over the next 20 years,
compared to the MDG scenario. While the MDG indica-
tors were selected because they have traditionally been
used for proxies of additional indicators, the evidence-
based interventions included in the All-In package rep-
resent a holistic package of the continuum of care for a
mother, newborn and young child [4, 7, 9, 46–49]. Our
results show that each LAC country would prevent sig-
nificant numbers of stillbirths, and greatly reduce mater-
nal, newborn and child deaths with this comprehensive
scale-up of basic healthcare services before, during and
after pregnancy.
There is much left to be done to avert preventable
stillbirths in the LAC region. Increased access to ANC,
facility-based delivery, and emergency obstetric and neo-
natal interventions has been shown to dramatically re-
duce stillbirths [6–8, 49]. This is consistent with our
modelling, which shows that the All-In intervention
package averted 235,532 stillbirths, representing a 67 %
increase in stillbirths prevented compared to the limited
package of MDG interventions.
The MDG intervention package also averted many
deaths, saving 60 %, 14 % and 50 % neonatal, under-five
and maternal lives, respectively, of the number of lives
saved by the All-In intervention package. The lower im-
pact made by the MDG intervention package may be
due to the much greater coverage of comprehensive emer-
gency obstetric and neonatal care, scale-up of exclusive
breastfeeding, increased vaccination coverage, and more
complete management of complications for the mother
and neonate in the All In scenario [4, 9, 48, 49].
Over the 20-year interval would be maternal lives, of
which the All-In intervention package was projected to
save 425 % more lives than the MDG only scenario. This
increase is linked to the scaling up of MgSO4 during ante-
natal care, access to emergency obstetric care, and maternal
sepsis case management in the All-In scenario, consistent
with recent studies showing their effectives in reducing ma-
ternal deaths [4, 9, 49]. Half – 50 % – maternal lives saved
Table 2 Number of additional lives saved and proportion of
deaths averted annually, by age group and intervention package,
in five-year increments
MDG All In
n (%)a n (%)a
Stillbirth 2020 3,320 (3.4) 7,384 (7.6)
2025 7,858 (8.1) 13,992 (14.5)
2030 10,702 (11.0) 15,969 (16.5)
2035 10,444 (10.8) 15,583 (16.1)
Neonatal 2020 3,505 (3.5) 32,867 (32.6)
2025 5,738 (5.7) 45,059 (44.7)
2030 7,242 (7.2) 44,162 (43.8)
2035 7,145 (7.1) 43,177 (42.8)
Under-five 2020 3,679 (1.9) 44,611 (22.8)
2025 5,762 (2.9) 56,463 (29.0)
2030 7,108 (3.6) 54,924 (28.0)
2035 6,999 (3.6) 54,145 (27.6)
Maternal 2020 991 (10.7) 2,522 (27.1)
2025 1,643 (17.7) 3,632 (39.1)
2030 2,109 (22.7) 3,615 (38.9)
2035 2,082 (22.4) 3,565 (38.3)
aDenominator is the average number of deaths that occurred annually
between 2009-2013
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by intervention scale-up through 2035 are due to imple-
mentation of the All-In scenario, demonstrating the need
to maintain high coverage of these vital interventions to
sustainably improve the health outcomes of mothers.
Measles coverage at baseline was already 90 % – 99 %
in all countries, resulting in few additional lives saved in
children between 1 and 5 years old by the MDG inter-
vention package [14]. Nearly one million lives of chil-
dren under five years old would be saved in the LAC
region with the implementation of the All-In interven-
tion package. In just the first year of implementation of
the All-In package, over 11,500 children’s lives would
be saved, and by 2030 over 55,000 children’s lives
would be saved annually; between 2020 and 2025, there
was a 31 % increase in the number of children saved
annually, increasing from 44,611 to 56,463. This is
likely due to the large increase in coverage of proven
MNCH interventions included in the All-In package
around childbirth, including emergency obstetric and
neonatal care, exclusive breastfeeding and vaccination
coverage [4, 49].
Our results show that approximately 78 % of the 1
million under-five deaths prevented in LAC between
2016 and 2035 would occur during the neonatal period.
This progress is attributable to increased coverage of
emergency obstetric and neonatal care [4, 9, 49]. Add-
itionally, the majority (90 %) of neonatal lives saved
would be from increased access to appropriate treatment
for prematurity, sepsis or asphyxia – the three largest
killers of neonates in the LAC region [50].
Global and regional initiatives, such as The Every
Newborn Action Plan (ENAP), aim to end preventable
stillbirths and newborn deaths through progress towards
achieving national indicators defined therein. For ex-
ample, ≤12 neonatal deaths per 1,000 live births and ≤12
stillbirths per 1,000 total births by 2030. Implementing
the interventions analyzed constitute a challenge on
achieving ENAP´s goals in LAC. Implementation re-
search analyzing coverage and bottlenecks regarding
these interventions are within research priorities, in
terms of guiding decision making on reducing newborn
and infant mortality. This requires strengthening the evi-
dence base for research, specifically monitoring and
evaluation that aims to changes in coverage, quality and
equity of care. As mentioned with regard to ENAP and
other public health initiatives, care provided and scaled
through these investments must be high quality in order
to achieve desired outcomes. Concurrent investments in
Fig. 2 Number of lives saved annually, by age group and intervention package, 2015-2035
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monitoring and evaluation of programs are required to
assure resource investments are optimally put to use for
mothers, newborns and children.
Previous analysis has demonstrated that when policy
attention, investment and informed planning are paired
with carefully tracked evidence-based interventions
coverage of specific interventions tend to improve,
resulting in better population health outcomes [51].
Monitoring and evaluating coverage and implementation
of key interventions are critical for i) strengthening their
implementation, ii) achieving the expected results, and
iii) reduce inequalities, as has been shown in this ana-
lysis. This will take considerable focus and persistence
from governmental, clinical and community personnel,
particularly for interventions that have relatively low
coverage at baseline, such as case management of severe
neonatal infection and exclusive breastfeeding for the
first six months of life.
Limitations
The most recent national-level coverage estimates for
each intervention were included in this analysis, though
we note great variance in the source year for baseline
coverage data. Additionally, there was inconsistency in
the value of a given indicator across various survey
methodologies, such as the MICS, DHS, and when com-
pared to various sources of national administrative data.
We did not model the impact of family planning, as the
focus of this study was to show the impact of expanding
the set of interventions on rates of mortality, as compared
to overall numbers of deaths. Research is needed to assess
how increasing the use, as well as changing the mix, of
contraceptives can contribute to averting deaths in LAC
especially for adolescents and other high-risk groups.
The assumptions used in LiST to develop estimates of
efficacy and impact are based on the latest guidance
from the global Child Health Epidemiology Reference
Group (CHERG). Nonetheless, the data used to develop
LiST modelling assumptions suffers from a relative scar-
city of LAC-specific studies on disease burden, efficacy
of interventions, as well as a lack of health coverage sur-
vey data. Further research is needed to develop more
LAC-specific metrics that could better account for re-
gional demographic and epidemiological trends. These
limitations were considered when evaluating the impact
for each group and intervention package, and were dis-
cussed with regional experts to help interpret the out-
puts of the LiST in the context of the LAC region.
Fig. 3 Number of neonatal lives saved annually, and from asphyxia, sepsis and prematurity, with the All In intervention package, 2015-2035
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While our analysis clearly illustrates the improved
health outcomes for mothers, newborns and children,
we did not assess the resources required for each inter-
vention package, some of which will likely require sub-
stantial investment. However, there have been increased
commitments and focus on improving health outcomes
for these groups at the global and regional levels, hinting
at the potential for continuing and new sources of fund-
ing for such initiatives. More research on cost effective-
ness and value for money are essential, to guide the
progression and sequencing of systematic reforms and
investments to realize universal coverage with a compre-
hensive package. We hope this spurs further dialogue
and research to better understand the economic, institu-
tional and political factors in each LAC country, at the
national and sub-national level, so as to invest in and
promote access to all lifesaving interventions.
Conclusions
Averting preventable maternal, newborn and child deaths,
and stillbirths, are a priority in the global health agenda,
but gaps in sufficient investment for a comprehensive set
of interventions remain. Our findings provide strong justi-
fication for investing in a broader set of effective, essential
MNCH interventions across the LAC region. Further re-
search – both empirical and operational – on effective
and efficient service delivery approaches is needed to en-
sure these interventions are well planned, adequately and
predictably resourced, while also monitored for quality,
equity and impact. The return on investment in a compre-
hensive MNCH package is clear: thousands of lives saved
and a greatly reduced burden of illness and disease, both
of which contribute to healthier families, communities
and countries.
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